Previous close | 0.8160 |
Open | 0.9155 |
Bid | 0.9580 x 200 |
Ask | 1.2700 x 200 |
Day's range | 0.7900 - 1.3500 |
52-week range | 0.4200 - 13.5100 |
Volume | |
Avg. volume | 7,286,009 |
Market cap | 23.669M |
Beta (5Y monthly) | 0.78 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.9800 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Institutional investors include affiliates of Off the Chain Capital and Discovery Capital ManagementMINNEAPOLIS, July 26, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade Real World Data ("RWD"), inclusive of electronic health records, laboratory results and, uniquely, medical imaging, today announced that it has entered into securities purchase agreements with certain institutional investors, including an affil
Cytel’s software products and services are utilized by hundreds of life science organizations, including the top 30 biopharmaceutical companiesMINNEAPOLIS, July 22, 2024 (GLOBE NEWSWIRE) -- Further to its press release dated June 14, 2024, OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade Real World Data (“RWD”), inclusive of electronic health records, laboratory results and, uniquely, medical imaging, announced today that Cytel Inc, (“C
- Regains compliance with Nasdaq minimum closing bid price rule - - Secures financing from institutional investor to support aggressive growth plans - MINNEAPOLIS, June 24, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade Real World Data ("RWD"), inclusive of electronic health records, laboratory results and, uniquely, medical imaging, today provided a number of corporate updates. “Over the past few weeks, we ha